Genticol

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Genticol

Quick Facts: Genticol

Property Description
Active Ingredient Gentamicin Sulfate
Common Forms Ophthalmic and Otic Solution/Drops, Ointment, Parenteral Solution
Pharmacological Class Aminoglycoside Antibiotic
General Purpose Provides anti-infective action against susceptible bacteria
Origin Natural product (derived from Micromonospora purpurea)

What Type of Medicine is Genticol and What is it Made Of?

Genticol is a medicinal preparation whose active ingredient is Gentamicin Sulfate, a potent anti-infective agent used to eliminate bacterial pathogens. It belongs to the aminoglycoside antibiotic class, and its primary purpose is to provide highly effective bactericidal action. The World Health Organization (WHO) includes Gentamicin on its Model List of Essential Medicines due to its efficacy and importance as an antibiotic. This classification highlights that the medicine is clinically recognized as crucial for basic healthcare systems.

Genticol is a single active ingredient product. The active substance, Gentamicin, has a natural origin, derived from the soil microorganism Micromonospora purpurea. The molecule works by targeting the bacterial cell's protein-building machinery, specifically the 30S ribosomal subunit, which forces the creation of nonfunctional proteins and ultimately destroys the infectious cell. This mechanism of action results in a potent ability to disrupt bacterial protein synthesis.


Purpose and Available Forms of Gentamicin Sulfate Preparations

The general purpose of Gentamicin Sulfate is to provide anti-infective action to clear up bacterial infections by rapidly and effectively eliminating bacterial pathogens. For instance, it is commonly used when treating bacterial infections that require localized antibiotic delivery. To achieve this, the product is offered in multiple dosage forms, providing versatility for targeted application. These forms include a sterile aqueous solution for ophthalmic (eye drops) or otic (ear drops) use, applying the drug topically directly to the site of infection. Additionally, it is available as a parenteral solution for intravenous or intramuscular administration, which allows the antibiotic to be distributed systemically throughout the body for more serious, deep-seated infections. This adaptability allows the antibiotic to be targeted to specific sites, which is a key differentiating factor of the Gentamicin class.

What side effects are possible with Genticol?

Possible side effects and safety information

The official safety profile for Gentamicin Sulfate (Genticol) is primarily defined by the risk of specific, dose-related toxicities characteristic of the aminoglycoside class, as documented in regulatory labeling.


Key Adverse Reaction Domains

Adverse reactions are formally categorized by frequency and affected organ system in regulatory documents, which highlights the risk of ototoxicity (Ear and Labyrinth disorders) and nephrotoxicity (Renal and Urinary disorders).

Classification Examples of Officially Documented Adverse Reactions
Common Renal function impairment (e.g., increased serum creatinine/urea)
Rare/Very Rare Polyneuropathies, vomiting, nausea, hypocalcaemia, vestibular damage, hearing loss, acute renal failure, thrombocytopaenia.

Serious Adverse Reactions and Toxicity Patterns

The most serious adverse reactions documented in regulatory sources include Irreversible Hearing Loss and Deafness, Acute Renal Failure, and Neuromuscular Blockade potentially leading to respiratory paralysis. The risk of these toxicities is noted to increase with a high total dose and long duration of therapy (e.g., over 5–7 days). Regulatory information notes that kidney impairment may become apparent even after treatment cessation.


Population-Specific Safety Considerations

The safety profile includes constraints for specific groups. Patients with renal impairment are at a higher risk of toxicity, and their dosage must be adjusted with close monitoring. For pregnant individuals, regulatory documents note the potential for fetal harm, including congenital deafness. Use in the elderly requires caution due to a higher susceptibility to toxicity.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose from Genticol (Gentamicin Sulfate) is characterized by manifestations of excessive drug accumulation, primarily affecting the renal and neurological systems as documented in regulatory information.

Documented Overdose Manifestations

Excessive serum concentrations are officially associated with Nephrotoxicity, evidenced by laboratory abnormalities like elevated serum creatinine and blood urea nitrogen. Ototoxicity affects the eighth cranial nerve, leading to hearing loss, tinnitus, and vestibular dysfunction (dizziness or vertigo). Neurotoxicity may also occur, presenting as convulsions, muscle twitching, or paresthesia.

Severe Outcomes and Emergency Actions

Life-threatening outcomes cited in regulatory documents include acute renal failure and respiratory paralysis resulting from severe neuromuscular blockade. Immediate medical attention must be sought for any signs of respiratory distress or suspected severe allergic reactions, such as anaphylaxis. Dosage adjustments or discontinuation of the drug are required upon evidence of toxicity.

Management and Monitoring Requirements

No specific chemical antidote is known for the overall toxicity syndrome; management is symptomatic and supportive. Regulatory guidance documents the use of hemodialysis to facilitate drug removal from the bloodstream. Close monitoring of renal function and gentamicin serum concentrations (peak and trough levels) is mandatory to identify and mitigate toxicity risk, especially in high-risk groups like the elderly or those with impaired renal function.

Therapeutic Uses of Genticol

Quick Facts

  • Therapeutic Domain: May be used to manage serious bacterial infections caused by susceptible organisms.
  • Key Areas: Blood infections (septicemia), meningitis, and severe infections of the urinary tract, skin, bones, and respiratory tract.
  • Ophthalmic Use: Available formulations may support the resolution of certain bacterial eye infections.

Genticol is a medication approved to support the management of various serious bacterial infections throughout the body. Its applications generally pertain to instances where a prompt therapeutic response is sought against susceptible strains of bacteria.

Key therapeutic domains include the treatment of blood infections, such as septicemia, and infections of the central nervous system, including meningitis. The agent is also utilized to address bacterial presence in the urinary tract, the respiratory system, the skin, bones, joints, and soft tissue. In these contexts, Genticol aims to reduce the bacterial load to facilitate clinical improvement.

For localized issues, such as infections of the eye, specific formulations are indicated for the topical treatment of conditions like conjunctivitis and keratitis caused by susceptible bacteria. The use of this drug is determined by a healthcare provider based on the type and severity of the infection.

Eligibility and Restrictions for Use

Who Can and Cannot Use Genticol?

Eligibility for Genticol (Gentamicin Sulfate) is strictly defined by regulatory documents, focusing on patient populations and pre-existing conditions.

Contraindicated Populations

Absolute prohibition from use is required for individuals with a known hypersensitivity to gentamicin or any other aminoglycoside antibiotic. Systemic use is contraindicated in patients with Myasthenia Gravis due to the risk of neuromuscular blockade. Furthermore, the otic formulation must not be used if there is a perforation of the eardrum.


Restrictions and Special Populations

Use requires caution and potential mandatory adjustment in several groups. Patients with impaired renal function or those of advanced age are at an increased risk of toxicity, necessitating close monitoring and adjustment of dosage. Pregnancy is a major restriction, as the medicine is contraindicated (Pregnancy Category D) due to the documented potential for fetal harm. While children, infants, and neonates are eligible for systemic use in serious infections, their treatment requires meticulous supervision.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information for Genticol (Gentamicin Sulfate) is structured primarily around the risk of additive toxicity and specific administration constraints.

Co-administration with other neurotoxic and/or nephrotoxic medicines should be avoided, as regulatory documents indicate a severe risk of enhanced toxicity. This category includes antibiotics like Vancomycin and certain chemotherapeutic agents such as Cisplatin. Similarly, concurrent use with potent diuretics (e.g., Furosemide or Ethacrynic acid) is restricted, as these may enhance toxicity by altering the antibiotic concentration in serum and tissue.

Pharmacodynamic and Physical Interactions

Interaction Type Interacting Substance(s) Official Constraint/Effect
Additive Effect Neuromuscular Blocking Agents May potentiate the effect, leading to enhanced neuromuscular blockade.
Synergism Penicillin-type Antibiotics Documented synergistic bactericidal effect (utilized therapeutically).
Physical Incompatibility Piperacillin/Tazobactam Requires mandatory physical separation during intravenous co-administration (not compatible via Y-site).

Population and Other Constraints

Patients with impaired renal function, advanced age, or dehydration are explicitly noted in regulatory documents as having an increased risk of interaction-related toxicity due to potential drug accumulation. Furthermore, Gentamicin has been associated with the urinary loss of Magnesium.

Mechanism of Action

Molecular Interference with Bacterial Protein Production

Genticol's active molecule acts as an inhibitor by achieving irreversible binding to the bacterial 30S ribosomal subunit. This key molecular interaction specifically involves the 16S ribosomal RNA at the decoding center. Binding to this site prevents the accurate translation of messenger RNA (mRNA) into proteins, which is essential for cellular growth and replication.


Destructive Cascade from Translational Fidelity Errors

The binding actively modulates translational fidelity, forcing the ribosome to misread the genetic code and rapidly produce nonfunctional, aberrant proteins. The accumulation of these toxic proteins then causes a significant disruption of the bacterial cell membrane integrity, which is the physiological mechanism that results in the bactericidal effect.


️ Biological Constraints and Mechanism Limitations

The effectiveness of this mechanism is constrained by two biological factors: the drug requires an oxygen-dependent active transport system to enter the bacteria, which limits its mechanism of action against anaerobic organisms. Furthermore, the action can be neutralized by acquired bacterial resistance, such as the production of enzymes that chemically inactivate the drug before it can reach its ribosomal target.

Dosage and Administration Information

Genticol's administration protocol is defined by the routes and weight-based dosing requirements. The drug is administered either systemically via Intramuscular (IM) injection or Intravenous (IV) infusion for deep-seated infections, or topically as a solution or ointment for ophthalmic, otic, or dermal use. Systemic dosing for serious infections is typically based on 3 mg/kg of the patient's body weight per day, with calculations for obese patients based on lean body mass to ensure accurate delivery. This total daily dose is commonly divided into three equal administrations given every 8 hours, although a once-daily regimen is recognized in certain adult contexts with normal renal function.

For intravenous administration, the parenteral solution must be diluted in a compatible fluid, such as sterile saline or dextrose, and infused slowly over a period of 30 minutes to 2 hours. The solution should not be physically premixed with other drugs. Dosage requires specific adjustment for certain patient groups: in cases of renal impairment, the dose or frequency must be reduced to prevent drug accumulation. Neonates and infants have a specialized regimen of 7.5 mg/kg/day in divided doses. The usual duration of systemic treatment is limited to 7 to 10 days. Throughout the course, monitoring of serum concentrations, specifically peak and trough levels, is performed to confirm adequate therapeutic exposure.

Recent Clinical Evidence

Genticol: Recent Clinical Evidence

Evidence for Use in Serious Systemic Bacterial Infections

Research has explored the use of Genticol in treating severe conditions, including blood infections (septicemia) and deep-seated infections. The evidence base comprises foundational clinical trials and modern observational studies, particularly in critical care settings. These studies primarily measure microbiological clearance of susceptible bacteria and survival rates over short periods. Findings show the medicine is frequently studied for use in combination with other antibiotics (like beta-lactams) for life-threatening cases. The assessment of its independent action is complicated by this common study design, and some systematic reviews indicate that when used in combination, the evidence regarding additive effects on survival was mixed in certain modern trials.


Evidence for Use in Central Nervous System Infections and Localized Uses

Research has also examined Genticol’s role in treating infections of the brain and spinal cord, such as bacterial meningitis, where studies monitor outcomes related to the sterilization of the cerebrospinal fluid. For localized applications, research on topical eye formulations exists, alongside cohort studies exploring local administration for complex, recurrent urinary tract infections (UTIs). These specialized studies monitor outcomes such as the frequency of recurrent symptomatic UTIs in specific patient cohorts.


Evidence Gaps and Limitations

The majority of studies were conducted over short time intervals, meaning there is limited information for long-term outcomes regarding the durability of response. Furthermore, comparative evidence against newer standard regimens is lacking in some areas. Study heterogeneity was observed across commercial products and testing devices, which may affect the predictability of results. Evidence for specialized uses is often limited to small, specific patient groups.

Frequently Asked Questions (FAQ)

Common questions about Genticol (FAQ)

Q: What is the main reason doctors prescribe Genticol?

A: Genticol, whose active ingredient is Gentamicin, is indicated by official labels for the treatment of serious infections caused by susceptible bacteria. These typically include bacterial blood infections (septicemia) and severe infections of the central nervous system, respiratory tract, and urinary tract. Regulatory documents indicate its use for severe, systemic infections.

Q: How quickly does Genticol usually start working?

A: As an injectable antibiotic, pharmacokinetic studies show that therapeutic levels are reached quickly. Official pharmacological information indicates that the concentration of the drug reaches its highest level in the blood approximately 30 minutes to 1 hour after it is administered.

Q: Does Genticol cause weight gain?

A: Based on regulatory documents detailing possible adverse effects, weight loss and decreased appetite are listed as potential reactions to Genticol. Weight gain is not mentioned in the official product information.

Q: Is a headache a normal side effect when starting Genticol?

A: Yes, headache is listed in regulatory documents as a possible adverse reaction. Other potential reactions that may occur include joint pain and fever. Any severe or persistent headache should be discussed with a healthcare provider.

Q: Can Genticol cause drowsiness or make you tired?

A: Official information lists unusual tiredness or weakness as a potential side effect. Although rare, more severe effects like lethargy have also been noted. Unexpected or severe fatigue should be discussed with a healthcare professional.

Q: What should I avoid eating or drinking while using Genticol?

A: Official dietary instructions generally advise patients to continue their normal diet while using Genticol. Unless a healthcare provider gives specific instructions, there are typically no particular foods or drinks that need to be avoided.

Q: Does Genticol interact with common pain relievers like ibuprofen?

A: Official documents state that caution is required when Genticol is used alongside certain non-steroidal anti-inflammatory drugs (NSAIDs). These pain relievers can potentially decrease the rate at which gentamicin is eliminated from the body, leading to higher concentrations in the blood.

Q: Is there any food that can stop Genticol from working?

A: No specific food is mentioned in official regulatory documents as being able to stop Genticol from working. It is generally advised that individuals continue their normal diet while on the medication.

Q: Is Genticol safe for use in older adults?

A: Official information advises that Genticol should be used with caution in geriatric (older) patients. This is because physiological changes, such as a natural decrease in kidney function, can increase the risk of adverse effects like drug toxicity. Dosing and monitoring procedures are commonly adjusted based on official instructions for this population.

Q: Can people with liver problems use Genticol?

A: The risk of serious side effects, such as ear damage (ototoxicity), is noted to be enhanced by hepatic impairment (liver problems). The regulatory label indicates that use in this context requires careful clinical consideration and close monitoring.

Q: Is Genticol a safe option for someone who has high blood pressure?

A: Regulatory information indicates that Genticol has been associated with changes in blood pressure, including both high blood pressure (hypertension) and low blood pressure (hypotension). A patient's blood pressure should be monitored throughout the course of treatment.

Q: Does Genticol need to be taken at the exact same time every day?

A: For traditional, multi-dose regimens, maintaining the correct interval (e.g., every 8 hours) between doses is essential. Official guidance emphasizes that doses are given at the required timing to maintain therapeutic concentrations and reduce the potential for toxicity.

Q: What happens if I forget to take a dose of Genticol?

A: Because this medication is typically administered by a healthcare professional in a clinical setting, official guidelines advise that any suspected missed dose requires immediate consultation with a healthcare professional for guidance. This step is advised to ensure proper blood levels are maintained.

Q: How long does Genticol stay in your system after you stop taking it?

A: In individuals with normal kidney function, the half-life of Gentamicin is approximately 2 to 3 hours, meaning the amount of drug is halved in that time. It is important to know that the half-life is significantly extended, or increased, for people with impaired kidney function.

Q: Is it normal to feel a bit dizzy after taking Genticol?

A: Dizziness is a documented adverse reaction to Genticol. Official documents also list dizziness as a symptom of serious side effects related to inner ear damage (vestibular damage). Any occurrence of dizziness should be discussed with a healthcare professional.

Q: Can Genticol affect birth control pills?

A: Official interaction information indicates that Gentamicin may decrease the level or effect of some oral hormone contraceptives by altering the intestinal flora. This is recognized as a low risk of contraceptive failure for oral birth control forms.

Q: Are there any restrictions on driving while using Genticol?

A: Gentamicin may cause dizziness or vertigo in some individuals. Due to the potential for dizziness or vertigo, official information advises caution regarding driving or operating machinery until the patient knows how the medicine affects them.

Q: Does Genticol interact with alcohol, even in small amounts?

A: Official consumer information documents for the injectable form generally state that no specific information is available regarding a documented interaction between Gentamicin Injection and the consumption of alcohol.

Q: Is it true that Genticol can be less effective over time?

A: Official labels caution that the drug's effectiveness can be constrained by the development of bacterial resistance. Misuse or overuse can lead to the growth of bacteria that the drug cannot kill, meaning it may become less effective in fighting future infections.

Q: Can Genticol pass into breast milk?

A: Regulatory documents state that it is not known whether components of the drug are excreted into human milk. For this reason, official regulatory documents note that the drug should be administered with caution to a nursing woman.

Q: Is Genticol known to cause any long-term vision changes?

A: Official adverse reaction lists include visual disturbances as a possible side effect of Genticol. Additionally, the topical form used for the eyes can temporarily cause blurred vision.

Q: Can taking Genticol affect the results of blood tests?

A: Yes, taking Genticol may result in certain laboratory abnormalities. Official product information lists altered levels of liver enzymes and decreased blood levels of electrolytes such as calcium, magnesium, sodium, and potassium.

How should Genticol be stored and disposed of?

The storage and disposal of Gentamicin products, such as Genticol, must adhere strictly to officially documented regulatory requirements, which vary by formulation.

Official Storage Conditions

Dosage Form Required Temperature Protection Requirements
Injection 20 to 25 C (Controlled Room Temp) Keep in original container.
Ophthalmic Drops 20 to 25 C (Controlled Room Temp) Protect from light; avoid excessive heat.
Topical Cream/Ointment 15 to 30 C (Controlled Room Temp) Keep tightly closed.

All medication forms must be kept in the container they came in, tightly closed, and stored out of the sight and reach of children for safety.

Disposal Instructions

Unused or expired product should be returned via a drug take-back program. If this is unavailable, the medicine must be removed from its container, mixed with an unpalatable substance (like dirt or coffee grounds), placed in a sealed bag, and discarded in the household trash. Do not flush the medication down the toilet or pour it down a sink.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Genticol found in:

A-Z Index: